Our collaborators recently delivered two oral presentations at leading international conferences in the field of nanomedicine and biomaterials.

•At the 35th Annual Conference of the European Society for Biomaterials (ESB 2026), held in Antwerp, Belgium (7-11 September 2026), they presented “Fucoidan-functionalized Multilayer Nanoparticles for Targeting Activated Endothelial Cells”. The work investigated fucoidan-coated multilayer nanoparticles as a strategy to selectively target activated endothelial cells, employing a range of advanced in vitro approaches, including our SCADA-on-Chip microfluidic platform.

•A second oral presentation was delivered at the 9th Spanish Conference on Biomedical Applications of Nanomaterials (SBAN 2026) in Madrid, Spain (17-18 September 2026). Entitled “Fucoidan-engineered multilayer nanoparticles selectively target activated endothelial cells in microfluidic in vitro blood-brain barrier models”, the study explored nanoparticle targeting and transport across endothelial barriers, with SCADA-on-Chip contributing to the evaluation of nanoparticle performance under physiologically relevant flow conditions.

These presentations highlight ongoing collaborative efforts to advance targeted nanomedicine for vascular and blood-brain barrier applications.